Intellectual Property Management Plan

Intellectual Property Management Policy

Bonraybio Co., Ltd. is committed to continuously advancing its intellectual property (IP) management in order to protect R&D resources, sustain innovation capabilities, strengthen competitive advantages, enhance corporate profitability, achieve operational objectives, and ensure sustainable business development.

Bonraybio places great importance on the management and operation of its intellectual property. The Company has dedicated personnel responsible for IP management. When the R&D team develops a new technological concept or innovation, the dedicated IP personnel conduct a patent search after preliminary experiments and prototyping have confirmed its feasibility. The assessment focuses on two key indicators: Freedom-to-Operate (FTO) and Patentability.

FTO refers to whether the technology can be implemented without infringing upon existing third-party patent rights or encountering potential patent barriers. Patentability refers to whether the technology has sufficient novelty and inventive characteristics in light of prior art, thereby indicating a reasonable likelihood of obtaining patent protection.

If a technology is determined to have FTO, the Company proceeds with subsequent product development, manufacturing, and commercialization. Furthermore, if the technology is determined to be patentable, the Company develops a domestic and international patent filing strategy targeting major global markets for its products, including Taiwan, China, the United States, and Europe, in order to obtain patent protection for new technologies.

Intellectual Property Management Measures

1. The Company has established the Intellectual Property Rights Management Procedures to protect its operations and enhance corporate value. In addition, through review mechanisms implemented by the relevant operating units, the Company seeks to reduce the risk of intellectual property infringement and respect the intellectual property rights of others.

2. The personnel responsible for intellectual property management shall continuously monitor commercially available products, patent and trademark publications, and relevant intellectual property information. Such information is collected and provided to the R&D units for research and reference. If a product is suspected of infringing upon the Company's patents or trademarks, the Company shall purchase the product for further investigation by the R&D unit. Where necessary, legal action may be taken upon approval through the Company's internal authorization process.

3. Any licensing of patents or trademarks shall be documented through a patent or trademark license agreement executed with the licensee, clearly specifying the scope, territory, rights, and obligations of the parties.

4. Where a patent or trademark right is licensed or assigned:

• The licensor shall warrant that the relevant product or trademark does not infringe upon any patent rights, copyrights, trademark rights, or other intellectual property rights of any third party.

• The licensor shall warrant that the relevant product or trademark was independently designed, developed, and manufactured. If it was designed, developed, or manufactured in accordance with specifications provided by a third party, the licensor shall warrant that it has obtained valid and complete authorization from such third party.

• Intellectual property rights arising from works or inventions created by employees in the course of performing their duties shall be assigned to the Company without consideration.

Measures for Handling Infringement of Third-Party Intellectual Property Rights

• If purchased goods are suspected of infringing upon the patent rights, copyrights, trademark rights, or other intellectual property rights of a third party, the Company shall immediately suspend further orders, cancel pending orders, suspend delivery, or take other appropriate measures. Transactions may resume only after the matter has been clarified and it has been determined that no infringement has occurred.

• If any suspected infringement of patent rights, copyrights, trademark rights, or other intellectual property rights is identified, the matter shall be immediately reported to the responsible supervisor and submitted to the General Manager. A task force shall be established, together with external legal counsel where appropriate, to formulate appropriate response measures.

• The Company maintains and regularly updates a list of intellectual property disputes and infringement litigation and provides such information to the Finance and Accounting Department on a regular basis for assessment of any potential impact on the Company's financial statements.

Intellectual Property Reporting

The Company reports relevant intellectual property matters to the Board of Directors at least once a year. On November 10, 2025, the Company reported the following implementation results to the Board of Directors:

1. Patent Acquisition

As of the fourth quarter of 2025, the Company had filed a total of 111 patent applications worldwide, of which 93 patents had been granted and 18 applications remained pending.

2. Trademark Registration

As of the fourth quarter of 2025, a total of 70 trademarks had been approved and registered worldwide, with no trademark applications pending.

3. Trade Secret Protection

The Company has established the Intellectual Property Rights Management Procedures. Customers, suppliers, and other relevant external parties are required to execute Confidentiality Agreements, while employees are required to execute Employee Confidentiality Agreements, thereby strengthening the protection of the Company's trade secrets and confidential information.

4. Intellectual Property Infringement Incidents

Number of incidents involving infringement of third-party intellectual property rights: 0.